Viewing Study NCT06291935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2026-01-05 @ 3:40 PM
Study NCT ID: NCT06291935
Status: RECRUITING
Last Update Posted: 2025-03-28
First Post: 2024-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
Sponsor: VeonGen Therapeutics GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinitis Pigmentosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CNGA1 mutation View
None AAV2 View
None Gene Therapy View
None Eye disease View